EV/EBITDA
-3.96
+0.12+2.94%
Fri, 07 Feb 2025 21:02:02 GMT
Summary
- As of February 8, 2025, GALT EV/EBITDA is -3.96, with a rise of +0.12 (+2.94%) during the most recent trading day.
- Over the past year, GALT EV/EBITDA has dropped by -0.15 (-3.94%).
- GALT EV/EBITDA is now -8020.00% below its all-time high of 0.05.
Performance
GALT EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
GALT EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.9% | -3.0% | -5.8% |
| 1 m1 month | -2.1% | +2.0% | +4.0% |
| 3 m3 months | +38.0% | -38.1% | -54.8% |
| 6 m6 months | +19.8% | -19.6% | -37.6% |
| ytdytd | -0.8% | +0.8% | +1.6% |
| 1 y1 year | -3.9% | +9.6% | -18.6% |
| 5 y5 years | +46.0% | +65.5% | -48.2% |
GALT EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -9.1% | -4.08 | +2.9% | |
| 3 m | 3-month | -3.21 | -23.4% | -6.71 | +41.0% |
| 6 m | 6-month | -3.21 | -23.4% | -6.71 | +41.0% |
| 1 y | 1-year | -3.21 | -23.4% | -8.54 | +53.6% |
| 3 y | 3-year | -2.05 | -93.2% | -8.54 | +53.6% |
| 5 y | 5-year | -2.05 | -93.2% | -10.37 | +61.8% |
| alltime | all time | 0.05 | -8020.0% | -35.88 | +89.0% |
Galectin Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.96(+0.8%) |
| 2024 | -3.93(+1.0%) |
| 2023 | -3.89(+66.2%) |
| 2022 | -2.34(-37.4%) |
| 2021 | -3.74(-13.4%) |
| 2020 | -4.32(-50.6%) |
| 2019 | -8.75(-10.8%) |
| 2018 | -9.81(+36.6%) |
| 2017 | -7.18(+808.9%) |
| 2016 | -0.79(-26.2%) |
| 2015 | -1.07(-65.7%) |
| 2014 | -3.12(-72.7%) |
| Date | Value |
|---|---|
| 2013 | -11.42(+379.8%) |
| 2012 | -2.38(-61.9%) |
| 2011 | -6.24(-41.1%) |
| 2010 | -10.60(+351.1%) |
| 2009 | -2.35(+193.8%) |
| 2008 | -0.80(-81.0%) |
| 2007 | -4.21(+111.6%) |
| 2006 | -1.99(-83.4%) |
| 2005 | -11.99(+49.1%) |
| 2004 | -8.04(-55.5%) |
| 2003 | -18.05(+3.9%) |
| 2002 | -17.37 |
FAQ
- What is Galectin Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Galectin Therapeutics?
- What is GALT EV/EBITDA year-to-date change?
- What is Galectin Therapeutics EV/EBITDA year-on-year change?
What is Galectin Therapeutics EV/EBITDA?
The current EV/EBITDA of GALT is -3.96
What is the all time high EV/EBITDA for Galectin Therapeutics?
Galectin Therapeutics all-time high EV/EBITDA is 0.05
What is GALT EV/EBITDA year-to-date change?
Galectin Therapeutics EV/EBITDA has changed by -0.03 (-0.76%) since the beginning of the year
What is Galectin Therapeutics EV/EBITDA year-on-year change?
Over the past year, GALT EV/EBITDA has changed by -0.15 (-3.94%)